Clinical Trial

A Study to Assess the Relative Bioavailability of Different Subcutaneous Formulations ofAZD6234

Active, Not Recruiting Phase 1
View on ClinicalTrials.gov →
Summary
This study in healthy volunteers aims to compare blood levels and side effects after administration of different formulations of AZD6234. This study will take place at one site in Nottingham, United Kingdom, and will enrol 21 healthy men and women aged 18-55 years.
Protocol Amendment History 6 changes
critical Enrollment closed, study ongoing 2026-08-14
minor Completion pushed: 2027-04-01 -> 2027-05-21 2026-08-14
critical Trial status changed: Active, Not Recruiting → Recruiting 2026-05-19
notable Enrollment increased: 19 -> 21 participants 2026-05-09
notable Primary completion pushed: 2026-03-24 -> 2026-09-09 2026-05-09
minor Completion pushed: 2026-03-25 -> 2027-04-01 2026-05-09
Trial Details
NCT Number NCT07220954
Lead Sponsor AstraZeneca
Collaborators: Quotient Sciences
Conditions Healthy Participants
Enrollment 19 participants
Start Date 2025-11-11
Primary Completion 2026-09-17 (estimated)
Study Completion 2027-05-21 (estimated)
Updated on ClinicalTrials.gov 2026-08-13